Bone Marrow Transplantation - Table of Contents alert Volume 47 Issue 9

TABLE OF CONTENTS Volume 47, Issue 9 (September 2012) In this issue Editorial Reviews Original Articles Letters to the Editor Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement If you are unable to access the articles in this Table of Contents e-alert in full, your library may not subscribe to this journal. Library recommendation through our online recommendation form is a simple way to make your librarian aware that this journal is valuable to your research. Recommend now.   Editorial Top Markov model of CLL transplants R P Gale Bone Marrow Transplant 2012 47: 1145-1146; 10.1038/bmt.2012.72 Full Text Reviews Top Stem cell transplant for Waldenström macroglobulinemia: an underutilized technique M A Gertz, C B Reeder, R A Kyle and S M Ansell Bone Marrow Transplant 2012 47: 1147-1153; advance online publication, August 29, 2011; 10.1038/bmt.2011.175 Abstract | Full Text Novel agents and approaches for stem cell mobilization in normal donors and patients Ş M Bakanay and T Demirer Bone Marrow Transplant 2012 47: 1154-1163; advance online publication, August 29, 2011; 10.1038/bmt.2011.170 Abstract | Full Text Original Articles Top CONDITIONING REGIMENS Comparing efficacy of reduced-toxicity allogeneic hematopoietic cell transplantation with conventional chemo-(immuno) therapy in patients with relapsed or refractory CLL: a Markov decision analysis M A Kharfan-Dabaja, J Pidala, A Kumar, T Terasawa and B Djulbegovic Bone Marrow Transplant 2012 47: 1164-1170; advance online publication, May 7, 2012; 10.1038/bmt.2012.71 Abstract | Full Text Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning J Casper, J Holowiecki, R Trenschel, H Wandt, K Schaefer-Eckart, T Ruutu, L Volin, H Einsele, G Stuhler, L Uharek, I Blau, M Bornhaeuser, A R Zander, K Larsson, M Markiewicz, S Giebel, T Kruzel, H A Mylius, J Baumgart, U Pichlmeier, M Freund and D W Beelen Bone Marrow Transplant 2012 47: 1171-1177; advance online publication, December 12, 2011; 10.1038/bmt.2011.242 Abstract | Full Text Population pharmacokinetics of cyclophosphamide in patients with thalassemia major undergoing HSCT P Balasubramanian, S Desire, J C Panetta, K M Lakshmi, V Mathews, B George, A Viswabandya, M Chandy, R Krishnamoorthy and A Srivastava Bone Marrow Transplant 2012 47: 1178-1185; advance online publication, January 9, 2012; 10.1038/bmt.2011.254 Abstract | Full Text CORD BLOOD STEM CELLS Unrelated cord blood transplantation for newly diagnosed patients with severe acquired aplastic anemia using a reduced-intensity conditioning: high graft rejection, but good survival H-L Liu, Z-M Sun, L-Q Geng, X-B Wang, K-Y Ding, B-I Tang, J Tong and Z-Y Wang Bone Marrow Transplant 2012 47: 1186-1190; advance online publication, January 16, 2012; 10.1038/bmt.2011.251 Abstract | Full Text PEDIATRIC TRANSPLANTS Enteral nutrition: a first option for nutritional support of children following allo-SCT? S Azarnoush, B Bruno, L Beghin, D Guimber, B Nelken, I Yakoub-Agha and D Seguy Bone Marrow Transplant 2012 47: 1191-1195; advance online publication, January 9, 2012; 10.1038/bmt.2011.248 Abstract | Full Text ALLOGRAFTING Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT K Perruccio, F Topini, A Tosti, A Carotti, E Burchielli, L Ruggeri, A Mancusi, E Urbani, F Aversa, M F Martelli and A Velardi Bone Marrow Transplant 2012 47: 1196-1200; advance online publication, December 5, 2011; 10.1038/bmt.2011.237 Abstract | Full Text Patients receiving HLA-haploidentical/partially matched related allo-HSCT can achieve desirable health-related QoL that is comparable to that of patients receiving HLA-identical sibling allo-HSCT X-D Mo, L-P Xu, D-H Liu, Y-H Chen, W Han, X-H Zhang, H Chen, Y Wang, J-Z Wang, K-Y Liu and X-J Huang Bone Marrow Transplant 2012 47: 1201-1205; advance online publication, January 9, 2012; 10.1038/bmt.2011.250 Abstract | Full Text A constitutional variant in the transcription factor EP300 strongly influences the clinical outcome of patients submitted to allo-SCT B Martín-Antonio, I Álvarez-Laderas, R Cardesa, F Márquez-Malaver, A Baez, M Carmona, J Falantes, M Suarez-Lledo, F Fernández-Avilés, C Martínez, M Rovira, I Espigado and Á Urbano-Ispizua Bone Marrow Transplant 2012 47: 1206-1211; advance online publication, January 9, 2012; 10.1038/bmt.2011.253 Abstract | Full Text AUTOGRAFTING Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance G V Manson, E Campagnaro, A Balog, D Kaplan, S R Sommers, P Fu, S V Rajkumar and H M Lazarus Bone Marrow Transplant 2012 47: 1212-1216; advance online publication, December 12, 2011; 10.1038/bmt.2011.244 Abstract | Full Text MICROBIAL ISSUES Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy P Ljungman, A Locasciulli, V G de Soria, A N Békássy, L Brinch, I Espigado, A Ferrant, I M Franklin, J O'Riordan, M Rovira, P Shaw and H Einsele for the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation Bone Marrow Transplant 2012 47: 1217-1221; advance online publication, December 12, 2011; 10.1038/bmt.2011.238 Abstract | Full Text Viral loads and antiviral resistance of herpesviruses and oral ulcerations in hematopoietic stem cell transplant recipients M T van der Beek, A M G A Laheij, J E Raber-Durlacher, P A von dem Borne, R Wolterbeek, C S van der Blij-de Brouwer, C van Loveren, E C J Claas, A C M Kroes, J J de Soet and A C T M Vossen Bone Marrow Transplant 2012 47: 1222-1228; advance online publication, February 13, 2012; 10.1038/bmt.2012.2 Abstract | Full Text POST-TRANSPLANT EVENTS Induction of multiple myeloma-reactive T cells during post-transplantation immunotherapy with donor lymphocytes and recipient DCs K Broen, A Greupink-Draaisma, H Fredrix, N Schaap and H Dolstra Bone Marrow Transplant 2012 47: 1229-1234; advance online publication, January 16, 2012; 10.1038/bmt.2011.258 Abstract | Full Text PRE-CLINICAL STUDIES Increased longevity and metabolic correction following syngeneic BMT in a murine model of mucopolysaccharidosis type I D A Wolf, A W Lenander, Z Nan, E A Braunlin, K M Podetz-Pedersen, C B Whitley, P Gupta, W C Low and R S McIvor Bone Marrow Transplant 2012 47: 1235-1240; advance online publication, December 19, 2011; 10.1038/bmt.2011.239 Abstract | Full Text Letters to the Editor Top Fecal calprotectin in allogeneic stem cell transplantation for the diagnosis of acute intestinal graft versus host disease M Bastos Oreiro, C Castilla-Llorente, A L de la Guía, R de Paz, M Van Domselaar, J Nieto, A Rodriguez, D Gallardo and M Canales on behalf of GETH (Grupo Español de Trasplantes Hematopoyéticos y Terapia Celular) Bone Marrow Transplant 2012 47: 1241-1242; advance online publication, February 6, 2012; 10.1038/bmt.2011.241 Full Text Post-transplant endothelial disorder after hematopoietic SCT: a blinded autopsy study S Goyama, K Takeuchi, Y Kanda, Y Nannya, S Chiba, M Fukayama and M Kurokawa Bone Marrow Transplant 2012 47: 1243-1245; advance online publication, December 19, 2011; 10.1038/bmt.2011.243 Full Text Graft vs GIST? S G Holtan, S R Palmer, S H Okuno and W J Hogan Bone Marrow Transplant 2012 47: 1246-1247; advance online publication, January 9, 2012; 10.1038/bmt.2011.247 Full Text Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease A Brioli, E Zamagni, S Pasquali, P Tosi, P Tacchetti, G Perrone, L Pantani, A Petrucci, B A Zannetti, M Baccarani and M Cavo Bone Marrow Transplant 2012 47: 1248-1249; advance online publication, January 9, 2012; 10.1038/bmt.2011.252 Full Text Constrictive pericarditis and primary effusion lymphoma following allogeneic BMT for CML H Rose, M Kulik, R Standish, E Prewett, R McLennan, J Szer and P Campbell Bone Marrow Transplant 2012 47: 1250-1251; advance online publication, January 16, 2012; 10.1038/bmt.2011.255 Full Text Successful use of second cord blood transplantation to achieve long-term remission in cord blood donor cell-derived AML harboring a FLT3-ITD and an NPM1 mutation K Chonabayashi, T Kondo, K Yamamoto, Y Tanaka, Y Nagai, M Hishizawa and A Takaori-Kondo Bone Marrow Transplant 2012 47: 1252-1253; advance online publication, January 9, 2012; 10.1038/bmt.2011.256 Full Text A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita M A Kharfan-Dabaja, Z K Otrock, A Bacigalupo, R A Mahfouz, F Geara and A Bazarbachi Bone Marrow Transplant 2012 47: 1254-1255; advance online publication, January 16, 2012; 10.1038/bmt.2011.257 Full Text Antibodies to anti-thymocyte globulin in aplastic anemia patients have a negative impact on hematopoietic SCT C M Jol-van der Zijde, R G M Bredius, A M Jansen-Hoogendijk, F J Smiers, A C Lankester and M J D van Tol Bone Marrow Transplant 2012 47: 1256-1258; advance online publication, January 23, 2012; 10.1038/bmt.2011.259 Full Text Successful allogeneic cord blood transplantation in a patient with Evans syndrome leads to correction of hereditary angioedema type I as secondary effect A Klausegger, M Wiednig, C Urban, H Lackner, H Reiter, J W Bauer and W Aberer Bone Marrow Transplant 2012 47: 1259-1261; advance online publication, February 13, 2012; 10.1038/bmt.2012.7 Full Text Correlation between paraproteinaemia and viral reactivation after allo-SCT E Metafuni, S Giammarco, S Bellesi, P Chiusolo, L Laurenti, F Sorà, P Cattani, R Santangelo, S Manzara, G Leone and S Sica Bone Marrow Transplant 2012 47: 1262; advance online publication, February 13, 2012; 10.1038/bmt.2012.11 Full Text Response to ‘Correlation between paraproteinaemia and viral reactivation after allo-SCT’ P G Medd, A J Peniket and T J Littlewood Bone Marrow Transplant 2012 47: 1263; advance online publication, February 13, 2012; 10.1038/bmt.2012.12 Full Text Advertisement Stem Cells USA & Regenerative Medicine Congress 20 - 21 September 2012, The Charles Hotel, Boston, USA Stem Cells USA is the region's largest commercial stem cells conference. This year's event will focus on strategies and business models to help you navigate this increasingly challenging marketplace, and to ensure your stem cell and regenerative medicine gets to market. Register now   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.